Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of Arabidopsis Col-0 plants with wild type, arr1-1 knock-out, ARR1 over-expressor and ARR1-SRDX fusion protein over-expressor genotypes treated with 6-Benzyladenine for different lengths of time
Arabidopsis thaliana Col-0 plants and three other genotypes (ARR1 overexpressor, arr1-1 knockout, overexpressor of ARR1-SRDX fusion protein) were grown in liquid media (1/2 MS, 1 g/L sucrose, 0.5 g/L MES, pH 5.7) in a Percival AR-66L growth chamber at 24 oC, 16:8 h day:night cycle, and 100 µE light ...
ORGANISM(S): Arabidopsis thaliana 
2008-08-31 | E-MEXP-689 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of Arabidopsis Col-0 wild-type and 35S:ARR1-SRDX transgenic seedlings either induced with 6-Benzyladenine or mock-treated
6 days old Arabidopsis thaliana of Col-0 wild-type and 35S:ARR1-SRDX transgenic seedlings grown in liquid culture (1/2 MS, 1 g/L sucrose, 0.5 g/L MES, pH 5.7) were induced with either 5 µM 6-Benzyladenine (a cytokinin analog) for 15 or 120 min, or mock-treated 120 min as a control. These samples wer...
ORGANISM(S): Arabidopsis thaliana 
2008-07-03 | E-ATMX-11 | biostudies-arrayexpress
UnknownEvaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.
Not available
S-EPMC4275317 | biostudies-literature
UnknownInfluence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
Not available
S-EPMC6588890 | biostudies-literature
Sort   by:  
 Page size